Vor Biopharma Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Vor Biopharma Inc. (VOR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are VOR insiders buying or selling?
In the last 12 months, Vor Biopharma Inc. insiders reported 0 open-market purchases ($0) and 10 sales ($70.6M) — net selling of $70.6M. Since February 2021, Trabud has recorded 32 Form 4 filings for VOR: 4 buys ($73.6M) and 28 sells ($121.0M).
Source: SEC EDGAR Form 4
What stands out
- No Vor Biopharma Inc. insider made an open-market purchase in the last 12 months; the 10 reported open-market sales totaled $70.6M.
Key Statistics (February 2021 – Jul 21, 2026)
Total Form 4 filings
32
SEC EDGAR
Insider filers
5
Insider buys (4)
$73.6M
Insider sells (28)
$121.0M
Insider sentiment
Net sellingNet insider flow of $47.3M in net selling since February 2021, and $70.6M in net selling over the last 12 months.
Recent VOR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Peter Kolchinsky | 10% Owner | Sale | 213 | $19.75 | $4.2K | SEC ↗ |
| Apr 24, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 165.2K | $15.77 | $2.6M | SEC ↗ |
| Apr 21, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 630.4K | $16.14 | $10.2M | SEC ↗ |
| Apr 15, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 738.0K | $16.10 | $11.9M | SEC ↗ |
| Apr 10, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 620.1K | $16.50 | $10.2M | SEC ↗ |
| Apr 6, 2026 | Peter Kolchinsky | Director, 10% Owner | Sale | 849.3K | $17.10 | $14.5M | SEC ↗ |
| Oct 30, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 400.4K | $25.90 | $10.4M | SEC ↗ |
| Oct 28, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 221.2K | $28.06 | $6.2M | SEC ↗ |
| Oct 22, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 117.0K | $29.34 | $3.4M | SEC ↗ |
| Oct 21, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 37.5K | $30.19 | $1.1M | SEC ↗ |
| Oct 17, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 73.7K | $31.88 | $2.3M | SEC ↗ |
| Oct 17, 2025 | Peter Kolchinsky | Director, 10% Owner | Sale | 464.0K | $29.54 | $13.7M | SEC ↗ |
| Oct 15, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 96.7K | $31.08 | $3.0M | SEC ↗ |
| Oct 10, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 124.1K | $33.16 | $4.1M | SEC ↗ |
| Oct 8, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 98.4K | $36.12 | $3.6M | SEC ↗ |
| Oct 4, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 41.8K | $39.43 | $1.6M | SEC ↗ |
| Sep 19, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 447.3K | $1.54 | $688.9K | SEC ↗ |
| Sep 15, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 984.8K | $1.73 | $1.7M | SEC ↗ |
| Sep 11, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 1.3M | $1.95 | $2.5M | SEC ↗ |
| Sep 5, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 1.4M | $1.97 | $2.8M | SEC ↗ |
| Aug 29, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 1.4M | $2.01 | $2.8M | SEC ↗ |
| Aug 27, 2025 | Reprogrammed Interchange LLC | 10% Owner | Sale | 671.5K | $2.10 | $1.4M | SEC ↗ |
| Feb 18, 2025 | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale | 2.2K | $1.42 | $3.2K | SEC ↗ |
| Feb 12, 2025 | Eyal C. Attar | CHIEF MEDICAL OFFICER | Sale | 2.6K | $1.37 | $3.5K | SEC ↗ |
| Jan 3, 2025 | Reprogrammed Interchange LLC | 10% Owner | Purchase | 39.0M | $0.00 | $0 | SEC ↗ |
Showing the 25 most recent of 32 Form 4 filings for Vor Biopharma Inc..
Most active VOR insiders
- Reprogrammed Interchange LLC13 filings
- Peter Kolchinsky11 filings
- Eyal C. Attar4 filings
- Andrew J. Schwab2 filings
- Kush Parmar2 filings
Ask anything about VOR insider activity
Use Trabud's AI agent to query Vor Biopharma Inc.'s Form 4 history in plain English — "Show me VOR CEO purchases this year" or compare it against any other ticker.
Open the AI agentVOR insider trading FAQ
Are Vor Biopharma Inc. insiders buying or selling?
In the last 12 months, Vor Biopharma Inc. insiders reported 0 open-market purchases ($0) and 10 sales ($70.6M) — net selling of $70.6M. Since February 2021, Trabud has recorded 32 Form 4 filings for VOR: 4 buys ($73.6M) and 28 sells ($121.0M). Over the full record that is net selling of $47.3M.
How many insiders trade VOR stock?
5 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Vor Biopharma Inc.. The most recent filing was accepted on Jul 21, 2026.
Where does Trabud get VOR insider trading data?
All VOR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.